microdosing with semaglutide GLP-1 Chart: Tirzepatide and Microdosing Ozempic: Beyond Weight Loss

510% weight loss can significantly improve metabolic, renal, and cardiovascular outcomes

Youll need to submit: Some insurers also impose quantity limits (e.g., 30-day supply initially to monitor adherence) or step therapy (try older, cheaper drugs first)

In Part 1 we started discussing the study Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Weight Loss by Bartelt et al

HbA1c Reduction: In the SURPASS-2 trial, Mounjaro (15 mg) achieved a mean HbA1c reduction of 2.07% from baseline at week 40, compared to 1.89% for semaglutide 1 mg

We combine prescription medications, nutritional guidance, lifestyle coaching, and ongoing medical monitoring to help you lose weight, improve metabolic health, and maintain your results long-term